Clinical trial
The OPTIMA-Study: Optimized Treatment Identification at the Max Planck Institute of Psychiatry
NCT03287362 is registered in ClinicalTrials.gov with Max-Planck-Institute of Psychiatry as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The OPTIMA-Study: Optimized Treatment Identification at the Max Planck Institute of Psychiatry
- Lead sponsor
- Max-Planck-Institute of Psychiatry
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 13, 2017
- Completion date
- December 31, 2024
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.